Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_3
1
14%
Ph phase_2
1
14%
Ph not_applicable
4
57%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
N/A4 (66.7%)

Trials by Status

withdrawn114%
completed571%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7